bioRxiv · 10.1101/344309
clonealign: statistical integration of independent single-cell RNA & DNA-seq from human cancers
Abstract
Measuring gene expression of genomically defined tumour clones at single cell resolution would associate functional consequences to somatic alterations, as a prelude to elucidating pathways driving cell population growth, resistance and relapse. In the absence of scalable methods to simultaneously assay DNA and RNA from the same single cell, independent sampling of cell populations for parallel measurement of single cell DNA and single cell RNA must be computationally mapped for genome-transcriptome association. Here we present clonealign, a robust statistical framework to assign gene expression states to cancer clones using single-cell RNA-seq and DNA-seq independently sampled from an heterogeneous cancer cell population. We apply clonealign to triple-negative breast cancer patient derived xenografts and high-grade serous ovarian cancer cell lines and discover clone-specific dysregulated biological pathways not visible using either DNA-Seq or RNA-Seq alone.
Source connections
Explore related subjects
Keep this discovery
Campbell, K. R., Steif, A., Laks, E., Zahn, H., Lai, D., McPherson, A., Farahani, H., Kabeer, F., O'Flanagan, C., Biele, J., Brimhall, J., Wang, B., Walters, P., IMAXT Consortium,, Bouchard-Cote, A., Aparicio, S., Shah, S. P.. 2018-06-11. clonealign: statistical integration of independent single-cell RNA & DNA-seq from human cancers. https://doi.org/10.1101/344309
Cite the original work for its findings. Save a collection to share your selection of sources.